Clinical Trials Directory

Trials / Completed

CompletedNCT06908915

Long Pulse 1064 nm Nd:YAG Laser in the Treatment of Erythematotelangiectatic Rosacea and Other Erythematous Telangiectatic Facial Conditions

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Hawler Medical University · Academic / Other
Sex
All
Age
32 Years – 52 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical study is to assess the effectiveness of Nd:YAG laser 1064 nm in the long pulse mode in the treatment of signs of rosacea including the erythema of the face and telangiectasia. The used parameter of this laser was of very low energy (spot size: 5mm, fluence: 4.07 J/Cm2, energy: 800 millijoules (mJ) and frequency: 5 Hz. About 2-3 passes performed in each treatment session. Up to four sessions were performed for each patient with 2 weeks interval) and also its was expected to have minimal adverse effects.

Conditions

Interventions

TypeNameDescription
DEVICENd:YAG laser 1064 nmThe entire face of each patient with rosacea was treated with long-pulse 1064nm Nd:YAG laser. The parameters that been used were spot size: 5mm, fluence: 4.07 J/Cm2, energy: 800 mJ and frequency: 5 Hz. About 2-3 passes performed in each treatment session. Up to four sessions were performed for each patient with 2 weeks interval.

Timeline

Start date
2023-03-03
Primary completion
2023-11-01
Completion
2024-11-04
First posted
2025-04-03
Last updated
2025-04-03

Locations

1 site across 1 country: Iraq

Source: ClinicalTrials.gov record NCT06908915. Inclusion in this directory is not an endorsement.